Orion Portfolio Solutions’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-10,465
Closed -$688K – 1926
2024
Q4
$688K Buy
10,465
+321
+3% +$22.1K 0.01% 1227
2024
Q3
$716K Sell
10,144
-104
-1% -$7.25K 0.01% 1189
2024
Q2
$680K Sell
10,248
-89
-0.9% -$5.83K 0.01% 1165
2024
Q1
$702K Sell
10,337
-616
-6% -$40.7K 0.01% 1139
2023
Q4
$702K Sell
10,953
-1,035
-9% -$60.8K 0.01% 1087
2023
Q3
$707K Sell
11,988
-702
-6% -$43.1K 0.01% 1068
2023
Q2
$758K Buy
12,690
+1,398
+12% +$83.1K 0.01% 1058
2023
Q1
$660K Buy
11,292
+201
+2% +$12.1K 0.01% 1037
2022
Q4
$688K Buy
11,091
+336
+3% +$20.2K 0.02% 402
2022
Q3
$608K Sell
10,755
-30
-0.3% -$1.85K 0.02% 366
2022
Q2
$689K Sell
10,785
-48
-0.4% -$3.05K 0.03% 327
2022
Q1
$701K Sell
10,833
-96
-0.9% -$6.08K 0.02% 339
2021
Q4
$727K Buy
10,929
+2,622
+32% +$166K 0.02% 341
2021
Q3
$507K Sell
8,307
-237
-3% -$15.1K 0.02% 389
2021
Q2
$529K Sell
8,544
-822
-9% -$50K 0.02% 348
2021
Q1
$555K Sell
9,366
-393
-4% -$23.7K 0.02% 298
2020
Q4
$584K Sell
9,759
-1,032
-10% -$58.8K 0.03% 276
2020
Q3
$588K Sell
10,791
-858
-7% -$46.3K 0.03% 237
2020
Q2
$597K Sell
11,649
-1,056
-8% -$53.1K 0.03% 212
2020
Q1
$570K Sell
12,705
-1,971
-13% -$99.4K 0.04% 190
2019
Q4
$783K Buy
+14,676
New +$723K 0.06% 160

Other funds holding IHE

Orion Portfolio Solutions's IHE Position: Q1 2025 in Review

Orion Portfolio Solutions sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2025, closing a stake of 10,465 shares — an estimated $688K sold.

Orion Portfolio Solutions first reported a position in IHE in Q4 2019 and held it in 21 quarters. The position peaked at $783K in Q4 2019. 149 funds tracked by Wall St. Rank hold IHE as of Q1 2025.

  • Orion Portfolio Solutions reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2025 after selling out during the quarter.
  • Orion Portfolio Solutions sold 10,465 iShares US Pharmaceuticals ETF shares in Q1 2025, an estimated $688K.
  • Orion Portfolio Solutions first reported a position in iShares US Pharmaceuticals ETF in Q4 2019 and held it in 21 quarters.
  • Orion Portfolio Solutions's iShares US Pharmaceuticals ETF position peaked at $783K in Q4 2019.
  • 149 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.